[1]	DEVARBHAVI H, ASRANI SK, ARAB JP, et al. Global burden of liver disease: 2023 update[J]. J Hepatol, 2023, 79(2): 516-537. DOI: 10.1016/j.jhep.2023.03.017. 本文引用 [1]

[2]	WANG JQ, LI LL, HU A, et al. Inhibition of ASGR1 decreases lipid levels by promoting cholesterol excretion[J]. Nature, 2022, 608(7922): 413-420. DOI: 10.1038/s41586-022-05006-3. 本文引用 [1]

[3]	LIU W, CHAKRABORTY B, SAFI R, et al. Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer[J]. Nat Commun, 2021, 12(1): 5103. DOI: 10.1038/s41467-021-25354-4. 本文引用 [1]

[4]	HASSEN C BEN, GOUPILLE C, VIGOR C, et al. Is cholesterol a risk factor for breast cancer incidence and outcome?[J]. J Steroid Biochem Mol Biol, 2023, 232: 106346. DOI: 10.1016/j.jsbmb.2023.106346. 本文引用 [1]

[5]	LIANG ZC, ZHANG Z, TAN XN, et al. Lipids, cholesterols, statins and liver cancer: A Mendelian randomization study[J]. Front Oncol, 2023, 13: 1251873. DOI: 10.3389/fonc.2023.1251873. 本文引用 [2]

[6]

YU JJ, DU YZ, SU J, et al. Preventive effect and mechanism of Citri Reticulatae Pericarpium on hypercholesterolemia rats[J]. Chin Tradit Pat Med, 2021, 43(11): 2982-2988. DOI: 10.3969/j.issn.1001-1528.2021.11.009. 俞静静, 杜宇忠, 苏洁, 等. 陈皮对高胆固醇血症大鼠的预防作用及其机制[J]. 中成药, 2021, 43(11): 2982-2988. DOI: 10.3969/j.issn.1001-1528.2021.11.009. 本文引用 [1]

[7]	YANG F, KOU JJ, LIU ZZ, et al. MYC enhances cholesterol biosynthesis and supports cell proliferation through SQLE[J]. Front Cell Dev Biol, 2021, 9: 655889. DOI: 10.3389/fcell.2021.655889. 本文引用 [1]

[8]	XU HJ, ZHOU S, TANG QL, et al. Cholesterol metabolism: New functions and therapeutic approaches in cancer[J]. Biochim Biophys Acta Rev Cancer, 2020, 1874(1): 188394. DOI: 10.1016/j.bbcan.2020.188394. 本文引用 [2]

[9]	SAHA P, SHUMATE JL, CALDWELL JG, et al. Inter-domain dynamics drive cholesterol transport by NPC1 and NPC1L1 proteins[J]. eLife, 2020, 9: e57089. DOI: 10.7554/eLife.57089. 本文引用 [1]

[10]	van de SLUIS B, WIJERS M, HERZ J. News on the molecular regulation and function of hepatic low-density lipoprotein receptor and LDLR-related protein 1[J]. Curr Opin Lipidol, 2017, 28(3): 241-247. DOI: 10.1097/MOL.0000000000000411. 本文引用 [1]

[11]	BAZIOTI V, LA ROSE AM, MAASSEN S, et al. T cell cholesterol efflux suppresses apoptosis and senescence and increases atherosclerosis in middle aged mice[J]. Nat Commun, 2022, 13(1): 3799. DOI: 10.1038/s41467-022-31135-4. 本文引用 [1]

[12]

WANG PH, YUE ZZ, WEI XT, et al. Influence of extracts from Euphorbiae Semen before and after frosting on cholesterol efflux in Caco-2 cells through liver X receptor-adenosine triphosphate-binding cassette transporter A1 pathway[J]. Chin J Clin Pharmacol, 2023, 39(2): 201-205. DOI: 10.13699/j.cnki.1001-6821.2023.02.011. 王佩华, 岳珠珠, 魏晓彤, 等. 千金子制霜前后提取物通过肝X受体-腺苷三磷酸结合盒转运体A1信号通路对Caco-2细胞中胆固醇外流的影响[J]. 中国临床药理学杂志, 2023, 39(2): 201-205. DOI: 10.13699/j.cnki.1001-6821.2023.02.011. 本文引用 [1]

[13]	YAN CS, ZHENG L, JIANG ST, et al. Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity[J]. Cancer Cell, 2023, 41(7): 1276-1293. DOI: 10.1016/j.ccell.2023.04.016. 本文引用 [1]

[14]	CARDOSO D, PERUCHA E. Cholesterol metabolism: A new molecular switch to control inflammation[J]. Clin Sci (Lond), 2021, 135(11): 1389-1408. DOI: 10.1042/CS20201394. 本文引用 [1]

[15]	LIM MYC, HO HK. Pharmacological modulation of cholesterol 7α-hydroxylase (CYP7A1) as a therapeutic strategy for hypercholesterolemia[J]. Biochem Pharmacol, 2024, 220: 115985. DOI: 10.1016/j.bcp.2023.115985. 本文引用 [1]

[16]	TAN JME, COOK ECL, van den BERG M, et al. Differential use of E2 ubiquitin conjugating enzymes for regulated degradation of the rate-limiting enzymes HMGCR and SQLE in cholesterol biosynthesis[J]. Atherosclerosis, 2019, 281: 137-142. DOI: 10.1016/j.atherosclerosis.2018.12.008. 本文引用 [1]

[17]	FAULKNER R, JO Y. Synthesis, function, and regulation of sterol and nonsterol isoprenoids[J]. Front Mol Biosci, 2022, 9: 1006822. DOI: 10.3389/fmolb.2022.1006822. 本文引用 [1]

[18]	FAULKNER RA, YANG YY, TSIEN J, et al. Direct binding to sterols accelerates endoplasmic reticulum-associated degradation of HMG CoA reductase[J]. Proc Natl Acad Sci U S A, 2024, 121(7): e2318822121. DOI: 10.1073/pnas.2318822121. 本文引用 [1]

[19]	JIANG LY, JIANG W, TIAN N, et al. Ring finger protein 145 (RNF145) is a ubiquitin ligase for sterol-induced degradation of HMG-CoA reductase[J]. J Biol Chem, 2018, 293(11): 4047-4055. DOI: 10.1074/jbc.RA117.001260. 本文引用 [1]

[20]	van den BOOMEN DJH, VOLKMAR N, LEHNER PJ. Ubiquitin-mediated regulation of sterol homeostasis[J]. Curr Opin Cell Biol, 2020, 65: 103-111. DOI: 10.1016/j.ceb.2020.04.010. 本文引用 [1]

[21]	MENZIES SA, VOLKMAR N, van den BOOMEN DJ, et al. The sterol-responsive RNF145 E3 ubiquitin ligase mediates the degradation of HMG-CoA reductase together with gp78 and Hrd1[J]. eLife, 2018, 7: e40009. DOI: 10.7554/eLife.40009. 本文引用 [1]

[22]	ALI N, ALLAM H, BADER T, et al. Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism[J]. PLoS One, 2013, 8(11): e80304. DOI: 10.1371/journal.pone.0080304. 本文引用 [2]

[23]	ALANNAN M, TRÉZÉGUET V, AMOÊDO ND, et al. Rewiring lipid metabolism by targeting PCSK9 and HMGCR to treat liver cancer[J]. Cancers (Basel), 2022, 15(1): 3. DOI: 10.3390/cancers15010003. 本文引用 [1]

[24]	JIANG W, HU JW, HE XR, et al. Statins: A repurposed drug to fight cancer[J]. J Exp Clin Cancer Res, 2021, 40(1): 241. DOI: 10.1186/s13046-021-02041-2. 本文引用 [1]

[25]	ESLAMI Z, AGHILI SS, GHAFI AG. Atorvastatin on treatment of nonalcoholic fatty liver disease patients[J]. Chonnam Med J, 2024, 60(1): 13-20. DOI: 10.4068/cmj.2024.60.1.13. 本文引用 [1]

[26]	WANG HJ, LIU SY, ZHOU CJ, et al. Fatal hepatic failure following atorvastatin treatment: A case report[J]. Medicine (Baltimore), 2023, 102(19): e33743. DOI: 10.1097/MD.0000000000033743. 本文引用 [1]

[27]	TORRE P, AGLITTI A, MASARONE M, et al. Viral hepatitis: Milestones, unresolved issues, and future goals[J]. World J Gastroenterol, 2021, 27(28): 4603-4638. DOI: 10.3748/wjg.v27.i28.4603. 本文引用 [1]

[28]	GLITSCHER M, HILDT E. Endosomal cholesterol in viral infections - A common denominator?[J]. Front Physiol, 2021, 12: 750544. DOI: 10.3389/fphys.2021.750544. 本文引用 [1]

[29]	HSU CS, LIU WL, LI QS, et al. Hepatitis C virus genotypes 1-3 infections regulate lipogenic signaling and suppress cholesterol biosynthesis in hepatocytes[J]. J Formos Med Assoc, 2020, 119(9): 1382-1395. DOI: 10.1016/j.jfma.2020.03.018. 本文引用 [1]

[30]	LI YJ, ZHU P, LIANG Y, et al. Hepatitis B virus induces expression of cholesterol metabolism-related genes via TLR2 in HepG2 cells[J]. World J Gastroenterol, 2013, 19(14): 2262-2269. DOI: 10.3748/wjg.v19.i14.2262. 本文引用 [1]

[31]	LIN SH, HUANG KJ, WENG CF, et al. Exploration of natural product ingredients as inhibitors of human HMG-CoA reductase through structure-based virtual screening[J]. Drug Des Devel Ther, 2015, 9: 3313-3324. DOI: 10.2147/DDDT.S84641. 本文引用 [1]

[32]	THONGSRI P, PEWKLIANG Y, BORWORNPINYO S, et al. Curcumin inhibited hepatitis B viral entry through NTCP binding[J]. Sci Rep, 2021, 11(1): 19125. DOI: 10.1038/s41598-021-98243-x. 本文引用 [1]

[33]

NAN C. Predictive value of triglyceride to high density lipoprotein cholesterol ratio combined with γ-glutamyl transpeptidase in nonalcoholic fatty liver disease[J]. Hebei Med J, 2023, 45(3): 385-387, 391. DOI: 10.3969/j.issn.1002-7386.2023.03.015. 南忱. 三酰甘油与高密度脂蛋白胆固醇比值联合γ-谷氨酰转肽酶对非酒精性脂肪性肝病的预测价值[J]. 河北医药, 2023, 45(3): 385-387, 391. DOI: 10.3969/j.issn.1002-7386.2023.03.015. 本文引用 [1]

[34]	TEWARI DN, BISWAS A, CHAKRABARTI AK, et al. AMFR promotes innate immunity activation and proteasomal degradation of HMGCR in response to influenza virus infection in A549 cells[J]. Virology, 2023, 587: 109875. DOI: 10.1016/j.virol.2023.109875. 本文引用 [1]

[35]	LI XZ, JIANG SY, LI GQ, et al. Synthesis of heterocyclic ring-fused analogs of HMG499 as novel degraders of HMG-CoA reductase that lower cholesterol[J]. Eur J Med Chem, 2022, 236: 114323. DOI: 10.1016/j.ejmech.2022.114323. 本文引用 [2]

[36]	LI ZY, ZHOU Y, JIA KW, et al. JMJD4-demethylated RIG-I prevents hepatic steatosis and carcinogenesis[J]. J Hematol Oncol, 2022, 15(1): 161. DOI: 10.1186/s13045-022-01381-6. 本文引用 [1]

[37]	HONG T, ZOU J, YANG J, et al. Curcumin protects against bisphenol A-induced hepatic steatosis by inhibiting cholesterol absorption and synthesis in CD-1 mice[J]. Food Sci Nutr, 2023, 11(9): 5091-5101. DOI: 10.1002/fsn3.3468. 本文引用 [1]

[38]

ZHAO CZ, JIANG W, ZHU YY, et al. Highland barley Monascus purpureus Went extract ameliorates high-fat, high-fructose, high-cholesterol diet induced nonalcoholic fatty liver disease by regulating lipid metabolism in golden hamsters[J]. J Ethnopharmacol, 2022, 286: 114922. DOI: 10.1016/j.jep.2021.114922. 本文引用 [1]

[39]	TONG J, LAN XT, ZHANG Z, et al. Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: Potential involvement of PANoptosis[J]. Acta Pharmacol Sin, 2023, 44(5): 1014-1028. DOI: 10.1038/s41401-022-01010-5. 本文引用 [1]

[40]	RAZA S, RAJAK S, UPADHYAY A, et al. Current treatment paradigms and emerging therapies for NAFLD/NASH[J]. Front Biosci (Landmark Ed), 2021, 26(2): 206-237. DOI: 10.2741/4892. 本文引用 [1]

[41]

KAMINSKY-KOLESNIKOV Y, RAUCHBACH E, ABU-HALAKA D, et al. Cholesterol induces Nrf-2- and HIF-1 α-dependent hepatocyte proliferation and liver regeneration to ameliorate bile acid toxicity in mouse models of NASH and fibrosis[J]. Oxid Med Cell Longev, 2020, 2020: 5393761. DOI: 10.1155/2020/5393761. 本文引用 [1]

[42]	VIJAYAN DK, PERUMCHERRY RAMAN S, DARA PK, et al. In vivo anti-lipidemic and antioxidant potential of collagen peptides obtained from great hammerhead shark skin waste[J]. J Food Sci Technol, 2022, 59(3): 1140-1151. DOI: 10.1007/s13197-021-05118-0. 本文引用 [1]

[43]	GUO J, XIE YA. Advances in the mechanism of immune microenvironment regulation of metastatic liver cancer[J]. Hebei Med J, 2023, 45(8): 1238-1243. 郭驹, 谢裕安. 免疫微环境调控转移性肝癌机制研究进展[J]. 河北医药, 2023, 45(8): 1238-1243. 本文引用 [1]

[44]	SAITO Y, YIN DZ, KUBOTA N, et al. A therapeutically targetable TAZ-TEAD2 pathway drives the growth of hepatocellular carcinoma via ANLN and KIF23[J]. Gastroenterology, 2023, 164(7): 1279-1292. DOI: 10.1053/j.gastro.2023.02.043. 本文引用 [1]

[45]

LI FY, WANG MG, MAO DW, et al. Association of lipid metabolism reprogramming with the development and progression of primary liver cancer[J]. J Clin Hepatol, 2024, 40(8): 1688-1692. DOI: 10.12449/JCH240829. 李飞燕, 王明刚, 毛德文, 等. 脂代谢重编程与原发性肝癌发生发展的关系[J]. 临床肝胆病杂志, 2024, 40(8): 1688-1692. DOI: 10.12449/JCH240829. 本文引用 [1]

[46]	FASOLATO S, PIGOZZO S, PONTISSO P, et al. PCSK9 levels are raised in chronic HCV patients with hepatocellular carcinoma[J]. J Clin Med, 2020, 9(10): 3134. DOI: 10.3390/jcm9103134. 本文引用 [1]

[47]	ROSOFF DB, BELL AS, WAGNER J, et al. Assessing the impact of PCSK9 and HMGCR inhibition on liver function: Drug-target mendelian randomization analyses in four ancestries[J]. Cell Mol Gastroenterol Hepatol, 2024, 17(1): 29-40. DOI: 10.1016/j.jcmgh.2023.09.001. 本文引用 [1]

[48]	ZHANG SZ, ZHU XD, FENG LH, et al. PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma[J]. Exp Hematol Oncol, 2021, 10(1): 25. DOI: 10.1186/s40164-021-00218-1. 本文引用 [1]

[49]	CHE L, CHI WN, QIAO Y, et al. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans[J]. Gut, 2020, 69(1): 177-186. DOI: 10.1136/gutjnl-2018-317581. 本文引用 [1]

[50]	WEI MK, NURJANAH U, HERKILINI A, et al. Unspliced XBP1 contributes to cholesterol biosynthesis and tumorigenesis by stabilizing SREBP2 in hepatocellular carcinoma[J]. Cell Mol Life Sci, 2022, 79(9): 472. DOI: 10.1007/s00018-022-04504-x. 本文引用 [2]

[51]	CHEN JR, DING CF, CHEN YH, et al. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway[J]. Cancer Lett, 2021, 502: 154-165. DOI: 10.1016/j.canlet.2020.12.019. 本文引用 [1]

[52]	WANG HY, SHU L, LV CR, et al. BRCC36 deubiquitinates HMGCR to regulate the interplay between ferroptosis and pyroptosis[J]. Adv Sci (Weinh), 2024, 11(11): e2304263. DOI: 10.1002/advs.202304263. 本文引用 [1]

[53]	SELITSKY SR, DINH TA, TOTH CL, et al. Transcriptomic analysis of chronic hepatitis B and C and liver cancer reveals microRNA-mediated control of cholesterol synthesis programs[J]. mBio, 2015, 6(6): e01500-15. DOI: 10.1128/mBio.01500-15. 本文引用 [1]

[54]	DING WJ, CHEN LL, XIA JG, et al. Causal association between lipid-lowering drugs and cancers: A drug target Mendelian randomization study[J]. Medicine (Baltimore), 2024, 103(18): e38010. DOI: 10.1097/MD.0000000000038010. 本文引用 [1]

[55]	JINDAL A, SARIN SK. Epidemiology of liver failure in Asia-Pacific Region[J]. Liver Int, 2022, 42(9): 2093-2109. DOI: 10.1111/liv.15328. 本文引用 [1]

[56]

YANG C, YANG HS, HU JH, et al. Effect of serum total cholesterol level on prognosis of patients with liver failure[J]. Chin J Integr Tradit West Med Liver Dis, 2021, 31(11): 1053-1056. DOI: 10.3969/j.issn.1005-0264.2021.11.027. 杨诚, 杨华升, 胡建华, 等. 血清总胆固醇水平对肝衰竭患者预后的影响[J]. 中西医结合肝病杂志, 2021, 31(11): 1053-1056. DOI: 10.3969/j.issn.1005-0264.2021.11.027. 本文引用 [1]

[57]	TANAKA S, de TYMOWSKI C, STERN J, et al. Relationship between liver dysfunction, lipoprotein concentration and mortality during sepsis[J]. PLoS One, 2022, 17(8): e0272352. DOI: 10.1371/journal.pone.0272352. 本文引用 [1]

[58]	ALVAREZ-SOLA G, URIARTE I, LATASA MU, et al. Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications[J]. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(4 Pt B): 1326-1334. DOI: 10.1016/j.bbadis.2017.06.025. 本文引用 [1]

[59]

LIN Y, YAN GJ, FENG F, et al. Association between cholesterol and liver regeneration and its significance and potential value in clinical treatment of liver failure[J]. J Clin Hepatol, 2022, 38(3): 708-713. DOI: 10.3969/j.issn.1001-5256.2022.03.044. 林镛, 颜耿杰, 冯逢, 等. 胆固醇与肝再生关系及其在肝衰竭治疗中的意义和潜在价值[J]. 临床肝胆病杂志, 2022, 38(3): 708-713. DOI: 10.3969/j.issn.1001-5256.2022.03.044. 本文引用 [1]

[60]	PENG J, YU JW, XU H, et al. Enhanced liver regeneration after partial hepatectomy in sterol regulatory element-binding protein (SREBP)-1c-null mice is associated with increased hepatocellular cholesterol availability[J]. Cell Physiol Biochem, 2018, 47(2): 784-799. DOI: 10.1159/000490030. 本文引用 [1]

[61]	SLABBER CF, BACHOFNER M, SPEICHER T, et al. The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration[J]. Sci Signal, 2023, 16(787): eade8029. DOI: 10.1126/scisignal.ade8029. 本文引用 [1]

[62]

LIEPINSH E, ZVEJNIECE L, CLEMENSSON L, et al. Hydroxymethylglutaryl-CoA reductase activity is essential for mitochondrial β-oxidation of fatty acids to prevent lethal accumulation of long-chain acylcarnitines in the mouse liver[J]. Br J Pharmacol, 2024, 181(16): 2750-2773. DOI: 10.1111/bph.16363. 本文引用 [1]

[63]	DENG Y, ZHAO Z, SHELDON M, et al. LIFR regulates cholesterol-driven bidirectional hepatocyte-neutrophil cross-talk to promote liver regeneration[J]. Nat Metab, 2024, 6(9): 1756-1774. DOI: 10.1038/s42255-024-01110-y. 本文引用 [1]

[64]	KOSHU K, MURAMATSU K, MARU T, et al. Neonatal onset of Niemann-Pick disease type C in a patient with cholesterol re-accumulation in the transplanted liver and inflammatory bowel disease[J]. Brain Dev, 2023, 45(9): 517-522. DOI: 10.1016/j.braindev.2023.06.006. 本文引用 [1]